Last updated on October 2018

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)


Brief description of study

This is a phase 3 randomized, placebo controlled study to evaluate the safety and anti-tumor activity of Avelumab in combination with standard of care chemoradiation (SoC CRT) versus SoC CRT alone in front-line treatment of patients with locally advanced head and neck cancer.

Clinical Study Identifier: NCT02952586

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

Sourasky Medical Center
Tel-Aviv, Israel
  Connect »

Pfizer CT.gov Call Center

The Chaim Sheba M.C.Tel-Hashomer
Ramat Gan, Israel
2.78miles
  Connect »

Pfizer CT.gov Call Center

Rabin Medical Center
Petah Tiqva, Israel
6.56miles
  Connect »